4//SEC Filing
Almenoff June Sherie 4
Accession 0001492647-25-000003
CIK 0000034956other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 6:43 PM ET
Size
11.7 KB
Accession
0001492647-25-000003
Insider Transaction Report
Form 4
Almenoff June Sherie
Director
Transactions
- Purchase
Common Stock
2025-11-17$7.15/sh+93$665→ 93 total - Purchase
Common Stock
2025-11-18$7.52/sh+1,900$14,280→ 1,993 total
Holdings
- 4
Stock Option (right to buy)
Exercise: $3200.00From: 2022-06-10Exp: 2031-06-10→ Common Stock (4 underlying) - 80,000
Stock Option (right to buy)
Exercise: $5.75From: 2026-07-01Exp: 2035-07-01→ Common Stock (80,000 underlying) - 4
Stock Option (right to buy)
Exercise: $992.00From: 2023-06-09Exp: 2032-06-09→ Common Stock (4 underlying) - 100,000
Stock Option (right to buy)
Exercise: $5.94From: 2025-12-10Exp: 2034-12-10→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $7.45 to $7.70. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Documents
Issuer
TENAX THERAPEUTICS, INC.
CIK 0000034956
Entity typeother
Related Parties
1- filerCIK 0001492647
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 6:43 PM ET
- Size
- 11.7 KB